Long-term use of osteoporosis drugs raises risk of fracturesFebruary 23rd, 2011 - 5:08 pm ICT by ANI
Washington, Feb 23 (ANI): A new study has revealed that women who take commonly prescribed drugs for osteoporosis known as bisphosphonates for five years or more may be at higher risk of certain kinds of fractures of their thigh bone.
However, the drugs do prevent hip fractures. And, since the overall risk of thigh bone fractures caused by the drugs is low, women at high risk for hip and other osteoporosis-related fractures should not stop taking bisphosphonates, according to researchers at St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences.
Typical hip fractures caused by osteoporosis occur in the upper part of the femur close to the hip joint and are an important cause of disability, need for long-term care and even death in the elderly. The risk of these kinds of fractures is reduced by bisphosphonate treatment, which was confirmed by this study.
But the study found that less common fractures lower down from the hip and closer to the middle of the femur -sometimes called “atypical” or “unusual” fractures — occurred more than 2.5 times as often in women who had taken bisphosphonates for more than five years than short-term users of the drug.
“Prolonged use of bisphosphonates is associated with rare and unusual fractures of the femur,” said the lead author, Laura Park-Wyllie, a pharmaceutical safety and outcomes researcher at St. Michael’s. “But the proven benefit of these drugs for the much more common fractures of osteoporosis usually outweighs the harm, especially in the initial years of treatment for osteoporosis. Women with osteoporosis, at high risk for osteoporotic fractures, should not stop taking bisphosphonate therapy because of the small risk of these thigh fractures.”
Park-Wyllie said the study was prompted by an increasing number of reports of thigh bone fractures among older women who have taken the drugs sold as Fosamax, Actonel or Didrocal for five years or more and by conflicting findings from small, observational studies.
The St. Michael’s-ICES study is the largest assessment of the issue to date. The researchers identified 205,466 women over age 68 who had been prescribed bisphosphonates between 2002 and 2008.
Of those, 716 women (0.35 per cent) had a fracture of the femur. These women were compared to other women of similar ages who had also been prescribed the drugs but who did not have femur fractures.
“Our study estimated that the risk of fractures to the femur was 0.13 per cent for women entering their sixth year on the drug - or just over one in 1,000,” Park-Wyllie said. “Use of bisphosphonates for less than five years was not associated with a significant risk of thigh fractures.”
About 50 per cent of women over 50 will suffer an osteoporosis-related fracture. The most common involve the wrist and the spine, but hip fractures can have some of the most severe consequences, with one in five of those women expected to die within 12 months.
The study has been published in the Journal of the American Medical Association (JAMA). (ANI)
- Osteoporosis drugs can raise fracture risk - Oct 17, 2010
- Wine could help protect older women from thinning bones - Aug 03, 2012
- FDA dissociates Fosamax from fractures - Mar 12, 2010
- Alzheimer's medication may increase risk of abnormally slow heart rate - Oct 02, 2009
- Diabetes drug raises bone fracture risk in older women - Feb 11, 2010
- Fracture prone? Blame your genes - Apr 22, 2012
- Keep tab on osteoporosis pain-reliever: Experts (Oct 20 is World Osteoporosis Day) - Oct 19, 2011
- Gene combinations linked to hip osteoporosis in postmenopausal women - Mar 30, 2011
- Long-term use of osteoporosis drug may weaken bones - Mar 11, 2010
- Obese kids at greater risk of bone fractures and osteoporosis in old age - Apr 11, 2011
- Try dietary calcium, Vitamin D for bone building - May 03, 2011
- Osteoporosis drug 'doubles cancer risk' - Sep 03, 2010
- Apple-shaped women 'more likely to develop osteoporosis' - Nov 30, 2010
- Drugs to fight bone thinning double cancer risk - Sep 03, 2010
- Bone loss drugs may cut breast cancer risk - Mar 03, 2010
Tags: actonel, bisphosphonates, bone fractures, clinical evaluative sciences, didrocal, fosamax, high risk, hip fractures, kinds of fractures, laura park, long term care, more than five years, older women, osteoporosis, osteoporosis drugs, osteoporotic fractures, researcher, s hospital, term users, thigh bone